FRAZIER LIFESCIENCES ACQUISITION CORPORATION Quotes Frazier Lifesciences Acquisition Corporation
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.95 EUR | -6.23% |
|
-8.96% | +80.93% |
| May. 09 | Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M | MT |
| May. 08 | NewAmsterdam Pharma Company N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quotes 5-day view
End-of-day quote Nasdaq| 2024-05-09 | 2024-05-10 | 2024-05-13 | 2024-05-14 | 2024-05-15 | |
|---|---|---|---|---|---|
| Last | 21.86 € | 21.43 € | 20.21 € | 20.5 € | 20.21 € |
| Volume | 89 962 | 78 305 | 107 664 | 134 715 | 107 664 |
| Change | +0.32% | -1.97% | -5.69% | +1.43% | -6.23% |
| Opening | 21.51 | 21.81 | 21.61 | 20.58 | 21.61 |
| High | 22.13 | 21.95 | 22.23 | 21.41 | 22.23 |
| Low | 21.31 | 21.05 | 20.18 | 20.32 | 20.18 |
Performance
| 1 day | -5.69% | ||
| 1 week | -8.96% | ||
| Current month | -7.34% | ||
| 1 month | +2.59% | ||
| 3 months | +0.80% | ||
| 6 months | +120.87% | ||
| Current year | +80.93% | ||
| 1 year | +55.46% | ||
| 3 years | +105.80% |
Volumes
marketsDaily volume
107 664
Avg. Volume 20 sessions
114 141
Avg. Volume 20 sessions
2 306 789.61
Avg. Volume 20 sessions USD
2 497 514.97
Record volume 1
2 900 962
Record volume 2
2 571 785
Record volume 3
1 904 169
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
1 678 365 422
Capitalization (USD)
1 817 132 675
Net sales (EUR)
13 005 070
Net sales (USD)
14 080 329
Number of employees
29
Sales / Employee (EUR)
448 451
Sales / Employee (USD)
485 529
Free-Float
94.27 %
Free-Float capitalization (EUR)
1 583 341 873
Free-Float capitalization (USD)
1 714 252 579
Average Daily Capital Traded
0.14%
Highs and lows
1 week
20.18
22.23
1 month
18.7523.01
Current year
11.1826.35
1 year
5.6326.35
3 years
5.6332.88
5 years
5.6332.88
10 years
5.6332.88
Indicators
Moving average 5 days
21.50
Moving average 20 days
21.25
Moving average 50 days
21.43
Moving average 100 days
19.76
Price spread / (MMA5)
+6.38%
Price spread / (MMA20)
+5.15%
Price spread / (MMA50)
+6.04%
Price spread / (MMA100)
-2.23%
STIM
RSI 9 days
34.48
RSI 14 days
41.15
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -5.69% | -8.96% | +80.93% | +55.46% | 1.82B | ||
| -0.31% | +4.47% | +5.33% | +23.37% | 111B | ||
| +0.79% | +1.51% | +12.11% | +32.28% | 105B | ||
| -0.47% | +1.54% | -12.56% | -12.31% | 22.34B | ||
| -3.33% | -9.77% | -3.70% | -10.64% | 21.93B | ||
| +1.76% | +0.65% | -6.03% | -29.42% | 18.59B | ||
| +2.06% | +3.26% | -35.21% | -28.81% | 18.12B | ||
| -0.86% | +0.13% | -10.86% | -32.55% | 16.96B | ||
| +1.71% | -3.29% | +5.10% | +43.19% | 13.7B | ||
| +0.73% | -2.48% | +37.57% | +10.37% | 12.45B | ||
| +0.21% | -8.93% | +289.58% | +221.79% | 7.98B | ||
| +3.28% | -3.50% | -26.24% | -36.83% | 7.82B | ||
| +0.43% | -0.05% | -0.38% | +32.29% | 7.66B | ||
| -5.45% | -8.21% | -0.90% | +30.84% | 7.54B | ||
| +2.55% | +0.55% | -51.01% | -68.51% | 7.53B | ||
| +2.61% | -0.15% | +7.35% | +36.25% | 7.15B | ||
| Average | +0.00% | -2.36% | +18.19% | +16.67% | ||
| Weighted average by Cap. | +0.18% | +0.70% | +7.79% | +16.48% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +83.53% | ||
| 2023 | +2.48% | ||
| 2022 | +11.79% | ||
| 2021 | -9.72% |
- Stock Market
- Equities
- NAMS Stock
- Quotes Frazier Lifesciences Acquisition Corporation